Rezonans magnetyczny jako obiecująca metoda diagnostyki chorób wątroby u psów

Piśmiennictwo

1. Caravan P., Ellison J.J., McMurry T.J., Lauffer R.B.: Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications. „Chem Rev”, 1999; 99: 2293-2352.
2. Chilla G.S., Tan C.H., Xu C., Poh C.L.: Diffusion weighted magnetic resonance imaging and its recent trend – a survey. „Quant Imaging Med Surg”, 2015; 5: 407-422.
3. Chu W.C.W., Leung T.F., Chan K.F., Yeung D.K.W., Yeung T.K., Cheung H.M., Hon E.K.L., Liew C.T., Lam W.W.M.: Wilson’s Disease With Chronic Active Hepatitis: Monitoring by in Vivo 31-Phosphorus MR Spectroscopy Before and After Medical Treatment. „AJR Am J Roentgenol”, 2004; 183: 1339-1342.
4. Cieszanowski A.: Zastosowanie badania rezonansu magnetycznego w onkologii. „Onkol Prak Klin”, 2013; 9, 2: 60-69.
5. Clifford C.A., Pretorius E.S., Weisse C., Sorenmo K.U., Drobatz K.J., Siegelman E.S., Solomon J.A.: Magneic Resonance Imaging of Focal Splenic and Hepatic Lesions In the Dog. „J Vet Intern Med”, 2004; 18: 330-8.
6. Hamm B., Staks T., Mühler A., Bollow M., Taupitz M., Frenzel T., Wolf K.J., Weinmann H.J., Lange L.: Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. „Radiology”, 1995; 195: 785-792.
7. Mariappan Y.K., Glaser K.J., Ehman R.L.: Magnetic Resonance elastography: a review. „Clin Anat”, 2010; 23: 497-511.
8. Mortele K.J., Ros P.R.: MR imaging in chronic hepatitis and cirrhosis. „Semin Ultrasound CT MR”, 2002; 23:79-100.
9. Nelson R.W., Couto C.G.: Small Animal Internal Diseases. 5^th Edition. Riverport Lane, Elsevier Health Sciences, 2014.
10. Reimer P., Rummeny E.J., Daldrup H.E., Hesse T., Balzer Th., Tombach B., Peters P.E.: Enhancement characteristics of liver metastases, hepatocellular carcinomas, and hemangiomas with Gd-EOB-DTPA: preliminary results with dynamic MR imaging. „Eur Radiol”, 1997; 7, 275-280.
11. Semelka R.C., Helmberger T.K.G.: Contrast Agents for MR Imaging of the Liver. „Radiology”, 2001; 218: 27-38.
12. Taouli B., Tolia A.J., Losada M., Babb J.S., Chan E.S., Bannan M.A., Tobias H.: Diffusion-weighted MRI for quantification of liver fibrosis: preliminary experience. „AJR Am J Roentgenol”, 2007; 189:799-806.
13. Thomson C.E., Kornegay J.N., Burn R.A., Drayer B.P., Hadley D.M., Levesque D.C., Gainsburg L.A., Lane S.B., Sharp N.J.H., Wheeler S.J.: Magnetic resonance imaging – a general overview of principles and examples in veterinary neurodiagnosis. „Vet Radiol Ultrasound”, 1993; 34: 2-17.

Lek. wet. Pola Borusewicz
Katedra Chorób Wewnętrznych z Kliniką Koni, Psów i Kotów,
Wydział Medycyny Weterynaryjnej,
Uniwersytet Przyrodniczy we Wrocławiu,
pl. Grunwaldzki 47, 50-366 Wrocław,
e-mail: pola.borusewicz@up.wroc.pl